Previous studies have observed the positive correlation between attenuated neuroinflammation and increased BDNF levels, which is presumed to be a possible mechanism underlying treatments for many neurological diseases such as multiple sclerosis [51], Parkinson’s disease [52], cognitive impairment [53-55], and mood disorders [56-58]. This evidence concerns the gene BDNF and multiple sclerosis.